PHGDH expression increases with progression of Alzheimer’s disease pathology and symptoms
- 3 May 2022
- journal article
- letter
- Published by Elsevier in Cell Metabolism
- Vol. 34 (5) , 651-653
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (P30AG062429, P50AG16573, R01GM138852, UG3CA256960)
- University of California San Diego
This publication has 10 references indexed in Scilit:
- Presymptomatic Increase of an Extracellular RNA in Blood Plasma Associates with the Development of Alzheimer’s DiseaseCurrent Biology, 2020
- Impairment of Glycolysis-Derived l-Serine Production in Astrocytes Contributes to Cognitive Deficits in Alzheimer’s DiseaseCell Metabolism, 2020
- The NMDA receptor activation by d -serine and glycine is controlled by an astrocytic Phgdh-dependent serine shuttleProceedings of the National Academy of Sciences, 2019
- A vicious cycle of β amyloid–dependent neuronal hyperactivationScience, 2019
- Single-cell transcriptomic analysis of Alzheimer’s diseaseNature, 2019
- Potential and Challenges for the Clinical Use of d-Serine As a Cognitive EnhancerFrontiers in Psychiatry, 2018
- A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer’s DiseaseCell Systems, 2017
- Profiling the human hippocampal proteome at all pathologic stages of Alzheimer's diseaseAlzheimer's & Dementia, 2016
- Brain-specific Phgdh Deletion Reveals a Pivotal Role for l-Serine Biosynthesis in Controlling the Level of d-Serine, an N-methyl-d-aspartate Receptor Co-agonist, in Adult BrainJournal of Biological Chemistry, 2010
- NMDA- and β-Amyloid1–42-Induced Neurotoxicity Is Attenuated in Serine Racemase Knock-Out MiceThe Journal of Neuroscience, 2008